• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术治疗主瓣狭窄合并混合性主动脉瓣病变后的左心室逆重构。

Left ventricular reverse remodeling after transcatheter aortic valve replacement for predominant aortic stenosis and mixed aortic valve disease.

机构信息

Department of Ultrasound, Second Affiliated Hospital (Xinqiao Hospital), Army Medical University, Chongqing, China.

出版信息

J Clin Ultrasound. 2023 Nov-Dec;51(9):1453-1460. doi: 10.1002/jcu.23585. Epub 2023 Oct 25.

DOI:10.1002/jcu.23585
PMID:37877538
Abstract

BACKGROUND

Mixed aortic valve disease (MAVD) is a frequent concomitant valve disease with unique cardiac pathological changes compared to predominant aortic stenosis (PAS). The previous studies about the MAVD are contradictory. Therefore, a new perspective is needed to assess the value of TAVR for this cohort of patients.

METHODS

From January 2018 to December 2021, 90 MAVD patients and 72 PAS patients who underwent TAVR in our hospital were collected. 1:1 propensity score matching analysis was used to control the bias in patient selection. The dynamic changes in left ventricular morphology and hemodynamics were compared by generalized estimating equations. Univariate or multivariate logistic regression analysis was used to screen for independent risk factors for the non-occurrence of left ventricular reverse remodeling (non-LVRR).

RESULTS

After the matching procedure, 112 patients were included in the analysis (56 in each group). Baseline characteristics were similar between the two groups. LVRR occurred in both groups, but MAVD had greater left ventricular end-diastolic volume index and left ventricular mass index, a higher incidence of mitral regurgitation (MR), and a more pronounced transformation of ventricular geometry patterns. Post-operative MR (odd ratio [OR]: 10.05; 95% confidence interval [CI]: 2.08-48.57; p < .001) and coronary artery disease (OR: 2.82; 95% CI: 1.08-7.34; p = .034) were independent risk factors for non-LVRR.

CONCLUSION

LVRR also occurs in patients with MAVD, post-operative MR and coronary artery disease were independent risk factors for non-LVRR.

摘要

背景

与主要主动脉瓣狭窄(PAS)相比,混合性主动脉瓣疾病(MAVD)是一种常见的伴发瓣膜疾病,具有独特的心脏病理变化。以前关于 MAVD 的研究结果相互矛盾。因此,需要新的视角来评估 TAVR 对这一组患者的价值。

方法

收集 2018 年 1 月至 2021 年 12 月在我院接受 TAVR 的 90 例 MAVD 患者和 72 例 PAS 患者。采用 1:1 倾向评分匹配分析来控制患者选择中的偏倚。采用广义估计方程比较左心室形态和血液动力学的动态变化。采用单变量或多变量逻辑回归分析筛选左心室逆向重构(non-LVRR)不发生的独立危险因素。

结果

匹配后,共有 112 例患者纳入分析(每组 56 例)。两组患者的基线特征相似。两组均发生 LVRR,但 MAVD 患者的左心室舒张末期容积指数和左心室质量指数更高,二尖瓣反流(MR)发生率更高,心室几何形态变化更为明显。术后 MR(比值比 [OR]:10.05;95%置信区间 [CI]:2.08-48.57;p<0.001)和冠心病(OR:2.82;95%CI:1.08-7.34;p=0.034)是 non-LVRR 的独立危险因素。

结论

MAVD 患者也会发生 LVRR,术后 MR 和冠心病是 non-LVRR 的独立危险因素。

相似文献

1
Left ventricular reverse remodeling after transcatheter aortic valve replacement for predominant aortic stenosis and mixed aortic valve disease.经导管主动脉瓣置换术治疗主瓣狭窄合并混合性主动脉瓣病变后的左心室逆重构。
J Clin Ultrasound. 2023 Nov-Dec;51(9):1453-1460. doi: 10.1002/jcu.23585. Epub 2023 Oct 25.
2
Impact of Transcatheter Aortic Valve Replacement on Cardiac Reverse Remodeling and Prognosis in Mixed Aortic Valve Disease.经导管主动脉瓣置换术对混合性主动脉瓣疾病心脏逆向重构及预后的影响
J Am Heart Assoc. 2024 Feb 20;13(4):e033289. doi: 10.1161/JAHA.123.033289. Epub 2024 Feb 16.
3
CMR quantitation of change in mitral regurgitation following transcatheter aortic valve replacement (TAVR): impact on left ventricular reverse remodeling and outcome.经导管主动脉瓣置换术(TAVR)后二尖瓣反流变化的心脏磁共振成像(CMR)定量分析:对左心室逆向重构及预后的影响
Int J Cardiovasc Imaging. 2019 Jan;35(1):161-170. doi: 10.1007/s10554-018-1441-y. Epub 2018 Sep 4.
4
Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease.经导管主动脉瓣置换术治疗混合性主动脉瓣疾病的结果。
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2299-2306. doi: 10.1016/j.jcin.2019.06.020. Epub 2019 Oct 30.
5
Assess the Outcomes of Transcatheter Aortic Valve Replacement in Bicuspid Valve with Mixed Disease versus Predominant Aortic Stenosis.评估二叶式主动脉瓣伴混合病变与主狭主导型行经导管主动脉瓣置换术的结局。
Clin Interv Aging. 2024 May 1;19:695-703. doi: 10.2147/CIA.S447272. eCollection 2024.
6
Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.经导管主动脉瓣置换术治疗低流量低梯度主动脉瓣狭窄患者的二尖瓣反流:TOPAS-TAVI 注册研究的见解。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):567-579. doi: 10.1016/j.jcin.2019.11.042. Epub 2020 Feb 12.
7
Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术后二尖瓣反流的转归和长期预后意义。
Int J Cardiol. 2019 Aug 1;288:39-43. doi: 10.1016/j.ijcard.2019.03.048. Epub 2019 Mar 27.
8
Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.心脏功能的可逆性可预测严重主动脉瓣狭窄患者经导管主动脉瓣置换术后的结局。
J Am Heart Assoc. 2017 Jul 11;6(7):e005798. doi: 10.1161/JAHA.117.005798.
9
Transcatheter aortic valve replacement outcomes in mixed aortic valve disease compared to predominant aortic stenosis.经导管主动脉瓣置换术治疗混合性主动脉瓣疾病与单纯主动脉瓣狭窄的疗效比较。
Int J Cardiol. 2020 Jan 15;299:209-214. doi: 10.1016/j.ijcard.2019.07.099. Epub 2019 Aug 1.
10
Left ventricular reverse remodeling after transcatheter aortic valve implantation in patients with low-flow low-gradient aortic stenosis.经导管主动脉瓣植入术治疗低流量低梯度主动脉瓣狭窄患者的左心室逆向重构。
Hellenic J Cardiol. 2023 Nov-Dec;74:1-7. doi: 10.1016/j.hjc.2023.04.009. Epub 2023 Apr 27.

引用本文的文献

1
Associations between new-onset postoperative atrial fibrillation and changes in left ventricular mass index in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术患者术后新发房颤与左心室质量指数变化之间的关联。
BMC Cardiovasc Disord. 2025 Apr 23;25(1):306. doi: 10.1186/s12872-025-04763-z.
2
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).在接受经导管主动脉瓣植入术(TAVI)的伴有严重主动脉瓣狭窄和心脏损伤的糖尿病患者中使用 SGLT2 抑制剂。
Cardiovasc Diabetol. 2024 Nov 21;23(1):420. doi: 10.1186/s12933-024-02504-8.